Lantus Solostar cartridge systems is an innovative delivery system for the long-acting form of the hormone insulin. Insulin helps regulate the amount of sugar present in the body by lowering the amount of glucose in the blood, a treatment most commonly associated with diabetes. This delivery system is used to improve glycemic control in both adults and children diagnosed with type 1 diabetes, as well as in adults diagnosed with type 2 diabetes.
The Lantus SoloStar insulin delivery system should be used once a day at the same time every day. Make sure the skin area where the injection will be made is clean and dry. Make the injection just under the skin of the abdomen, upper arms, or thighs, as directed by your physician. Do not rub the site of the injection before or after the shot. Do not inject the Insulin shot into a vein or muscle. To avoid skin irritation issues, change the location of the injection site daily.
Lantus is contraindicated against patients who happen to be hypersensitive to insulin glargine or one of its excipients. Lantus must never be diluted or mixed with any other insulin compound or solution, as the solution may become cloudy, and this may significantly effect the the onset of action of the solution. Do not use any other method to administer Lantus, such as insulin pumps or intravenously because severe hypoglycemia can occur. Remember that insulin devices and needles must never be shared with other patients.Blood glucose levels in patients treated with insulin must be closely monitored for any notable variations. A sudden drop in blood sugar levels could indicate hypoglycemia, which could also be dangerous.
Uses and dosage :
Adults and Children:
Give by SC inj once daily at same time each day into abdominal area, thigh, or deltoid; rotate inj sites. Onset one .1hrs, no pronounced peak, duration 24hrs or longer. <6yrs: not established. ≥6yrs: individualize; monitor and adjust as needed. Type 1 diabetes: Initially ⅓ of total daily insulin dose. Give remainder of the total dose as short-acting, premeal insulin. Insulin-naïve with type 2 diabetes: Initially 0.2 Units/kg or up to 10 Units once daily. May need to adjust amount, timing of short- or rapid-acting insulins and doses of any oral antidiabetics. Switching from once-daily Toujeo (insulin glargine 300 Units/mL): reduce initial Lantus dose by 20% of the previous Toujeo dose. Switching from a long- or intermediate-acting insulin regimen: may need to change basal insulin dose; and adjust the amount, timing of the short-acting insulins and doses of any oral antidiabetics. Switching from once-daily NPH: initial Lantus dose should be the same as previous NPH dose. Switching from twice-daily NPH: reduce initial Lantus dose by 20% of the previous total NPH dose.
During episodes of hypoglycemia.
Instruct patients on diet, exercise, blood or urine testing, proper administration of insulin, change in species of origin, type or purity of insulin, and management of hypoglycemia. Do not reuse or share pens, needles, or syringes between patients. Increased risk of hypoglycemia if changes in physical activity, meal patterns, renal or hepatic function, insulin regimen and if acute illness occurs: monitor glucose more frequently and may need to adjust dose. Monitor potassium levels in patients at risk for hypokalemia (eg, concomitant K+-lowering or K+-sensitive drugs). Pregnancy (monitor). Nursing mothers.
Along with its needed effects, insulin glargine (the active ingredient contained in Lantus) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
behavior change similar to being drunk
cool, pale skin
difficulty with thinking
dizziness or lightheadedness
tingling in the hands, feet, lips, or tongue
unusual tiredness or weakness
Less Common or Rare
skin rash or itching over the entire body
Incidence Not Known
Bloating or swelling of the face, hands, lower legs, or feet
difficulty with swallowing
muscle pain or cramps
numbness or tingling in the hands, feet, or lips
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
rapid weight gain